PubMed

Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.

Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF.

J Urol. 2009 Nov;182(5):2182-7. Epub 2009 Sep 15.PMID: 19758623 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer: quality of life after radiation and androgen deprivation.

Makarov DV, Penson DF.

Nat Rev Urol. 2009 Sep;6(9):477-8. No abstract available. PMID: 19727147 [PubMed - in process]Related articles

Access to information sources and treatment considerations among men with local stage prostate cancer.

Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF.

Urology. 2009 Sep;74(3):509-15. Epub 2009 Jul 9.PMID: 19589564 [PubMed - indexed for MEDLINE]Related articles

Erectile aid use by men treated for localized prostate cancer.

Bergman J, Gore JL, Penson DF, Kwan L, Litwin MS.

J Urol. 2009 Aug;182(2):649-54. Epub 2009 Jun 17.PMID: 19535108 [PubMed - indexed for MEDLINE]Related articles

Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort.

Penson DF, Wessells H, Cleary P, Rutledge BN; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

J Sex Med. 2009 Jul;6(7):1969-78. Epub 2009 Apr 28.PMID: 19453899 [PubMed - in process]Related articles

Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.

Nichol MB, Knight TK, Wu J, Barron R, Penson DF.

J Urol. 2009 May;181(5):2214-21; discussion 2221-2. Epub 2009 Mar 17.PMID: 19296986 [PubMed - indexed for MEDLINE]Related articles

Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.

Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG.

J Urol. 2009 May;181(5):2052-8; discussion 2058-9. Epub 2009 Mar 14.PMID: 19286213 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer: epidemiology and health-related quality of life.

Penson DF, Rossignol M, Sartor AO, Scardino PT, Abenhaim LL.

Urology. 2008 Dec;72(6 Suppl):S3-11.PMID: 19095126 [PubMed - indexed for MEDLINE]Related articles

Evaluating localized prostate cancer and identifying candidates for focal therapy.

Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT.

Urology. 2008 Dec;72(6 Suppl):S12-24.PMID: 19095124 [PubMed - indexed for MEDLINE]Related articles

The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy.

Stein JP, Penson DF.

Curr Urol Rep. 2008 May;9(3):179-81. No abstract available. PMID: 18765110 [PubMed - indexed for MEDLINE]Related articles

Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.

Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR.

Prostate. 2008 Sep 15;68(13):1477-86.PMID: 18618736 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project.

Huang GJ, Hamilton AS, Lo M, Stein JP, Penson DF.

J Urol. 2008 Aug;180(2):520-4; discussion 524. Epub 2008 Jun 11.PMID: 18550088 [PubMed - indexed for MEDLINE]Related articles

Invasive T1 bladder cancer: indications and rationale for radical cystectomy.

Stein JP, Penson DF.

BJU Int. 2008 Aug;102(3):270-5. Epub 2008 May 20. Review.PMID: 18494831 [PubMed - indexed for MEDLINE]Related articles

5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study.

Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL.

J Urol. 2008 May;179(5 Suppl):S40-4.PMID: 18405749 [PubMed]Related articles

Assessing the quality of prostate cancer care.

Penson DF.

Curr Opin Urol. 2008 May;18(3):297-302. Review.PMID: 18382239 [PubMed - indexed for MEDLINE]Related articles

Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach.

Etzioni R, Gulati R, Falcon S, Penson DF.

Med Decis Making. 2008 May-Jun;28(3):323-31. Epub 2008 Mar 4.PMID: 18319508 [PubMed - indexed for MEDLINE]Related articles

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, Thompson IM.

Am J Epidemiol. 2008 Apr 15;167(8):925-34. Epub 2008 Feb 7.PMID: 18263602 [PubMed - indexed for MEDLINE]Related articlesFree article

Internet health resources and the cancer patient.

Huang GJ, Penson DF.

Cancer Invest. 2008 Mar;26(2):202-7. Review.PMID: 18259953 [PubMed - indexed for MEDLINE]Related articles

Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.

Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP 3rd, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM.

Clin Cancer Res. 2008 Jan 1;14(1):224-9.PMID: 18172274 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantifying the role of PSA screening in the US prostate cancer mortality decline.

Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, Feuer E.

Cancer Causes Control. 2008 Mar;19(2):175-81. Epub 2007 Nov 20.PMID: 18027095 [PubMed - indexed for MEDLINE]Related articles

Quality of life after therapy for localized prostate cancer.

Penson DF.

Cancer J. 2007 Sep-Oct;13(5):318-26. Review.PMID: 17921731 [PubMed - indexed for MEDLINE]Related articles

Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.

Stein JP, Penson DF, Wu SD, Skinner DG.

J Urol. 2007 Sep;178(3 Pt 1):756-60. Epub 2007 Jul 13. Review.PMID: 17631333 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer.

Penson DF, Chan JM; Urologic Diseases in America Project.

J Urol. 2007 Jun;177(6):2020-9.PMID: 17509282 [PubMed - indexed for MEDLINE]Related articles

On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer.

Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF.

J Urol. 2007 Jun;177(6):1992-9. Review.PMID: 17509278 [PubMed - indexed for MEDLINE]Related articles

Pharmacoeconomics of available treatment options for metastatic prostate cancer.

Zeliadt SB, Penson DF.

Pharmacoeconomics. 2007;25(4):309-27. Review.PMID: 17402804 [PubMed - indexed for MEDLINE]Related articles

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM.

J Urol. 2007 Apr;177(4):1395-400; quiz 1591.PMID: 17382740 [PubMed - indexed for MEDLINE]Related articles

PSA screening and elderly men.

Singer EA, Penson DF, Palapattu GS.

JAMA. 2007 Mar 7;297(9):949; author reply 949-50. No abstract available. PMID: 17341705 [PubMed - indexed for MEDLINE]Related articles

13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.

Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J.

J Urol. 2007 Mar;177(3):932-6.PMID: 17296379 [PubMed - indexed for MEDLINE]Related articles

Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.

Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, Groshen S, Lieskovsky G, Skinner DG.

J Urol. 2007 Mar;177(3):876-81; discussion 881-2.PMID: 17296365 [PubMed - indexed for MEDLINE]Related articles

Trends in treatment costs for localized prostate cancer: the healthy screenee effect.

Zeliadt SB, Etzioni R, Ramsey SD, Penson DF, Potosky AL.

Med Care. 2007 Feb;45(2):154-9.PMID: 17224778 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE.

Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR; CaPSURE Investigators.

Urology. 2006 Dec;68(6):1242-7. Epub 2006 Dec 4.PMID: 17141841 [PubMed - indexed for MEDLINE]Related articles

Longitudinal differences in psychological outcomes for men with erectile dysfunction: results from ExCEED.

Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF.

J Sex Med. 2006 Nov;3(6):1068-76.PMID: 17100940 [PubMed - indexed for MEDLINE]Related articles

Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED.

Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF.

J Sex Med. 2006 Nov;3(6):1059-67.PMID: 17100939 [PubMed - indexed for MEDLINE]Related articles

Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.

Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG.

J Urol. 2006 Nov;176(5):2025-31; discussion 2031-2.PMID: 17070244 [PubMed - indexed for MEDLINE]Related articles

The effect of erectile dysfunction on quality of life following treatment for localized prostate cancer.

Penson DF.

Rev Urol. 2001 Summer;3(3):113-9.PMID: 16985703 [PubMed - in process]Related articlesFree article

Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer.

Zeliadt SB, Potosky AL, Penson DF, Etzioni R.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):395-402. Epub 2006 Aug 14.PMID: 16904843 [PubMed - indexed for MEDLINE]Related articles

Discussing quality-of-life issues with a patient newly diagnosed with prostate cancer.

Gore JL, Penson DF, Litwin MS.

Nat Clin Pract Urol. 2006 Aug;3(8):449-52.PMID: 16902521 [PubMed - indexed for MEDLINE]Related articles

Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other?

Yang CC, Porter MP, Penson DF.

BJU Int. 2006 Jul;98(1):105-9; discussion 109.PMID: 16831153 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer on the Internet--information or misinformation?

Black PC, Penson DF.

J Urol. 2006 May;175(5):1836-42; discussion 1842. Erratum in: J Urol. 2006 Aug;176(2):844. PMID: 16600774 [PubMed - indexed for MEDLINE]Related articles

Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.

Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW.

Cancer. 2006 May 1;106(9):1865-74.PMID: 16568450 [PubMed - indexed for MEDLINE]Related articlesFree article

Variations in prostate cancer patterns of care: is it the quality of care or the quality of the data?

Penson DF.

J Clin Oncol. 2005 Nov 1;23(31):7783-4. Epub 2005 Oct 11. No abstract available. PMID: 16219931 [PubMed - indexed for MEDLINE]Related articles

Laparoscopic urological oncology: here come the outcomes!

Penson DF.

J Urol. 2005 Oct;174(4 Pt 1):1174. No abstract available. PMID: 16145363 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer and the Will Rogers phenomenon.

Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, Fine J.

J Natl Cancer Inst. 2005 Sep 7;97(17):1248-53.PMID: 16145045 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.

Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM.

J Urol. 2005 Sep;174(3):877-81. Erratum in: J Urol. 2005 Nov;174(5):2071. PMID: 16093979 [PubMed - indexed for MEDLINE]Related articles

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.

Zeliadt SB, Etzioni RD, Penson DF, Thompson IM, Ramsey SD.

Am J Med. 2005 Aug;118(8):850-7.PMID: 16084177 [PubMed - indexed for MEDLINE]Related articles

An update on randomized clinical trials in localized and locoregional prostate cancer.

Penson DF.

Urol Oncol. 2005 Jul-Aug;23(4):280-8. Review.PMID: 16018945 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.

Penson DF, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M.

J Urol. 2005 Aug;174(2):547-52; discussion 552.PMID: 16006889 [PubMed - indexed for MEDLINE]Related articles

Quality of life in patients with localized prostate cancer.

Quek ML, Penson DF.

Urol Oncol. 2005 May-Jun;23(3):208-15. Review.PMID: 15907723 [PubMed - indexed for MEDLINE]Related articles

Quality of life issues in bladder cancer patients following cystectomy and urinary diversion.

Porter MP, Wei JT, Penson DF.

Urol Clin North Am. 2005 May;32(2):207-16. Review.PMID: 15862618 [PubMed - indexed for MEDLINE]Related articles

5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.

Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL.

J Urol. 2005 May;173(5):1701-5.PMID: 15821561 [PubMed - indexed for MEDLINE]Related articles